| Company/Division name | CordenPharma Colorado |
| Parent company | International Chemical Investors Group |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Boulder |
| State(s) reshored to: | CO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | low to mid-kg scale range peptides, peptide APIs |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market, Lean/other business process improvement techniques, Skilled workforce availability/training, Under-utilized capacity, Other, Covid-19 |
